Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
IMP-731 by Immutep for Plaque Psoriasis (Psoriasis Vulgaris): Likelihood of Approval
IMP-731 is under clinical development by Immutep and currently in Phase I for Plaque Psoriasis (Psoriasis Vulgaris). According to GlobalData,...